Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of aliskiren on renal haemodynamics and metabolic parameters in prediabetes
2008-008287-28Phase 3Completed
- Sponsor
- University Hospital Erlangen
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of aliskiren in prediabetes and hypertension (HTN), sponsored by University Hospital Erlangen. Primary endpoint: Renal haemodynamic parameters. Started Apr 2010; status: completed.
02
Drugs
aliskiren
03
Conditions
prediabeteshypertension (HTN)
Beyond the preview
Go deeper on 2008-008287-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008287-28.